Navigation Links
GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
Date:11/26/2007

hypertensives, and older and younger participants. Participants with Greater Than or Equal To 2 risk factors had risk reductions (RR) in both acute major coronary events (RR 43%) and coronary revascularization procedures (RR 37%). Because there were too few events among those participants with age as their only risk factor in this study, the effect of MEVACOR on outcomes could not be adequately assessed in this subgroup.

Figure 1

(Photo: http://www.newscom.com/cgi-bin/prnh/20071126/NEM105 )

Atherosclerosis

In the Canadian Coronary Atherosclerosis Intervention Trial (CCAIT), the effect of therapy with lovastatin on coronary atherosclerosis was assessed by coronary angiography in hyperlipidemic patients. In the randomized, double- blind, controlled clinical trial, patients were treated with conventional measures (usually diet and 325 mg of aspirin every other day) and either lovastatin 20-80 mg daily or placebo. Angiograms were evaluated at baseline and at two years by computerized quantitative coronary angiography (QCA). Lovastatin significantly slowed the progression of lesions as measured by the mean change per-patient in minimum lumen diameter (the primary endpoint) and percent diameter stenosis, and decreased the proportions of patients categorized with disease progression (33% vs. 50%) and with new lesions (16% vs. 32%).

In a similarly designed trial, the Monitored Atherosclerosis Regression Study (MARS), patients were treated with diet and either lovastatin 80 mg daily or placebo. No statistically significant difference between lovastatin and placebo was seen for the primary endpoint (mean change per patient in percent diameter stenosis of all lesions), or for most secondary QCA endpoints. Visual assessment by angiographers who formed a consensus opinion of overall angiographic change (Global Change Score) was also a secondary endpoint. By t
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine news :

1. GlaxoSmithKline Responds to JAMA Articles
2. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
3. Congressional Black Caucus Foundation and GlaxoSmithKline Announce Supplier Business Initiative Study Results
4. AUDIO from Medialink and GlaxoSmithKline: A New Nasal Spray for Allergy Relief
5. Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
6. GlaxoSmithKline Aids California Fire Relief Efforts
7. Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
8. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
9. Southwest Ambulance Awarded Exclusive, 3-Year Contract Extension in Peoria, Arizona
10. Crdentias VP of Marketing, Christina Hogan, Provides Exclusive Interview on Marketing Strategy
11. Pearson VUE Signs Exclusive Contract with Educational Resources, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 29, 2014) Using quality improvement measures in eight ... Cardiovascular Disease Study Group, researchers have found a way ... with contrast dye. , Currently, 7-15 percent of these ... end up with kidney injury, which can result in ... temporary or permanent dialysis, says a study published in ...
(Date:7/29/2014)... New York (PRWEB) July 29, 2014 ... behalf of individuals who allegedly suffered serious liver ... continue to move forward in a multidistrict litigation ... Pennsylvania, Bernstein Liebhard LLP reports. According to an ... certain deadlines pertaining to bellwether case and ...
(Date:7/29/2014)... By Alan Mozes ... -- Treating certain adult autism patients with just a single ... judge facial expressions and emotions, Japanese researchers report. Known ... a role in emotional bonding between lovers, and between mothers ... neural activity in a key area of the brain that ...
(Date:7/29/2014)... The Law Offices of Michael Cordova is proud ... non-profit organization providing grief camps for kids, teens, adults, and ... our clients experience from the death of a loved one. ... like Stepping Stones of Hope, as they provide hope and ... Hope also includes a monthly support group and a variety ...
(Date:7/29/2014)... receive steady follow-up care, the living donors themselves ... care more accessible, UC San Francisco and Walgreens ... the first program in the country that provides ... kidney donors. , UCSF will provide vouchers for ... Walgreens pharmacies and Healthcare Clinic at select Walgreens ...
Breaking Medicine News(10 mins):Health News:Reducing kidney injury using a quality improvement method 2Health News:Tylenol Lawsuit News: Federal Court Overseeing Tylenol Liver Damage Claims Sets New Deadlines Pertaining to Discovery, Bellwether Trials, Bernstein Liebhard LLP Reports 2Health News:Tylenol Lawsuit News: Federal Court Overseeing Tylenol Liver Damage Claims Sets New Deadlines Pertaining to Discovery, Bellwether Trials, Bernstein Liebhard LLP Reports 3Health News:Tylenol Lawsuit News: Federal Court Overseeing Tylenol Liver Damage Claims Sets New Deadlines Pertaining to Discovery, Bellwether Trials, Bernstein Liebhard LLP Reports 4Health News:'Love Hormone' Oxytocin May Help Some With Autism 2Health News:'Love Hormone' Oxytocin May Help Some With Autism 3Health News:The Law Offices of Michael Cordova is Sponsoring Stepping Stones of Hope, a Non-Profit Organization Providing Grief Camps for Kids, Teens, Adults, and Families 2Health News:Caring for donors 2Health News:Caring for donors 3
... , , KENILWORTH, N.J., Aug. 6 ... live Webcast of its Special Shareholders Meeting being held on Friday, ... between Schering-Plough and Merck & Co., Inc. Originating from Boston, ... corporate Web site, www.schering-plough.com . , , ...
... exposure associated with skin inflammation in study of myositis ... ultraviolet (UV) rays may trigger certain types of autoimmune ... "This study found that women who lived in areas ... an autoimmune muscle disease called myositis were more likely ...
... ... Health Letter focuses on the feet and their common ailments. Dr. James Ioli, chief of podiatry ... ... of our feet. They provide a steady base when we stand, serve as shock absorbers when ...
... Aug. 6 Vitamin Shoppe Industries Inc., a leading specialty ... will hold a conference call for its bondholders on Thursday, ... call, members of management will report on the Company,s second ... To participate in the teleconference, bondholders are invited to call ...
... BEIJING and BETHESDA, Md., Aug. 6 /PRNewswire-Asia/ -- ... ("Chindex") (Nasdaq: CHDX ), a leading,independent ... in,the People,s Republic of China, today announced that ... plans to,launch a comprehensive, international-standard oncology program, called ...
... , , SAN DIEGO, Aug. 6 AMN Healthcare Services, Inc. (NYSE: AHS ) today announced ... 2009 include: , , ... % Chg % Chg, ... Q2 2009 Q2 2008 Q1 2009, ------------------------------------------------------------, ...
Cached Medicine News:Health News:Sunlight May Cause Rash in Autoimmune Disease 2Health News:Harvard Health Letter Special Section Features the Body's Unsung Marvels: The Feet 2Health News:Chindex International, Inc. Launches World-Class Cancer Treatment Center 2Health News:Chindex International, Inc. Launches World-Class Cancer Treatment Center 3Health News:Chindex International, Inc. Launches World-Class Cancer Treatment Center 4Health News:AMN Healthcare Announces Second Quarter 2009 Results 2Health News:AMN Healthcare Announces Second Quarter 2009 Results 3Health News:AMN Healthcare Announces Second Quarter 2009 Results 4Health News:AMN Healthcare Announces Second Quarter 2009 Results 5Health News:AMN Healthcare Announces Second Quarter 2009 Results 6Health News:AMN Healthcare Announces Second Quarter 2009 Results 7Health News:AMN Healthcare Announces Second Quarter 2009 Results 8Health News:AMN Healthcare Announces Second Quarter 2009 Results 9Health News:AMN Healthcare Announces Second Quarter 2009 Results 10Health News:AMN Healthcare Announces Second Quarter 2009 Results 11Health News:AMN Healthcare Announces Second Quarter 2009 Results 12Health News:AMN Healthcare Announces Second Quarter 2009 Results 13Health News:AMN Healthcare Announces Second Quarter 2009 Results 14Health News:AMN Healthcare Announces Second Quarter 2009 Results 15Health News:AMN Healthcare Announces Second Quarter 2009 Results 16
(Date:7/29/2014)... YORK , July 29, 2014  Longtime industry ... Caremark Rx, Drew Crawford today announced the ... the leading independent media source dedicated to delivering fair, ... on the pharmacy benefit management (PBM) industry .  ... of, and context behind, industry news.   The outlet will ...
(Date:7/29/2014)... , July 29, 2014 McGraw-Hill Education Professional, ... the science, technical, and medical communities, has announced the ... off-line mobile application of the world-renowned medical education platform. ... AccessMedicine App , available for download onto all ... be able to gain access to valuable AccessMedicine ...
(Date:7/29/2014)... According to a new market ... Devices Market - Global Forecast, Market Share, Size, Growth ... trauma fixation devices market is estimated at USD 6.1 ... a CAGR of 7.2% from 2014 to 2019, to ... 2020. Browse the Orthopedic Trauma Fixation Devices ...
Breaking Medicine Technology:Drew Crawford Announces Launch of PBM365 Media 2McGraw-Hill Education Professional's AccessMedicine App Delivers Instant Access to Essential Diagnostic Tools 2McGraw-Hill Education Professional's AccessMedicine App Delivers Instant Access to Essential Diagnostic Tools 3Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 2Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 3Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 4
... This programmable system automates the denaturation ... procedures, and provides walk-away convenience for ... cost unit accepts a wide range ... use, and reduces hands-on time by ...
... DiffSpin Slide Spinner for technique independent ... wedge smears.,DiffSpin is a compact, quiet, ... the preparation of uniformly distributed cell ... with a start-up supply of slides ...
... systems deliver pulsed light over one smooth ... spikes (which may damage skin) that other ... sends a chilled water supply through the ... which is cooled to as low as ...
... small, quiet, high-speed centrifuge. It employs a ... results in nearly vibration- free operation. Light ... speed and full breaking in a few ... a simple push-on/ pull-off; transforming the centrifuge ...
Medicine Products: